Stephen K. Brannan
Director · Serina Therapeutics, Inc.
- 2025
- Jul 9, 2026
- 3
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Stephen K. Brannan files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Randall Moreadith - $377K in SER purchases and sales in the last 12 months
- Karen J. Wilson - $55K in SER purchases and sales in the last 12 months
- Richard Peter Marshall - $20K in SER purchases and sales in the last 12 months
- Jay Venkatesan - $1K in SER purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Stephen K. Brannan?
Stephen K. Brannan is a corporate insider, tracked as Director of Serina Therapeutics, Inc. (SER). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Stephen K. Brannan last file a Form 4?
The most recent primary Form 4 on record is dated 9 July 2026, one of 3 filings going back to 2025.
Has Stephen K. Brannan been buying or selling stock?
Recorded transactions: 1 open-market purchase ($2K) and 0 open-market sales across all tracked filings.
